How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
about
Intractable and highly active relapsing multiple sclerosis - role of alemtuzumabChanges and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuationThe outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population.Cardiovascular effects of fingolimod: A review article.Patient experience and practice trends in multiple sclerosis - clinical utility of fingolimod.Fingolimod after natalizumab and the risk of short-term relapse.Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis.
P2860
Q26783585-5330DD9F-48B3-4A51-8B42-5164BF0F16FEQ31009955-C1146E94-8401-4E47-8132-790E6E496FCBQ33562198-FB657204-42DF-4FDF-BFF7-2B3E30B9D49FQ33756452-5553FB17-21C4-49A2-AED1-4EC681604A61Q34558943-3B3F66A5-BDF0-4728-87F5-5CAD6CFF2BD3Q35659134-1178DA70-ACA5-4B90-AF70-6C37436DA3CEQ37725909-03FB85DF-F59A-46C0-A2B4-61566DDF51B6Q38192006-C464B9FD-0F43-456B-A9EF-C50C11FF1DD6
P2860
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
How does fingolimod (gilenya(® ...... -remitting multiple sclerosis?
@ast
How does fingolimod (gilenya(® ...... -remitting multiple sclerosis?
@en
type
label
How does fingolimod (gilenya(® ...... -remitting multiple sclerosis?
@ast
How does fingolimod (gilenya(® ...... -remitting multiple sclerosis?
@en
prefLabel
How does fingolimod (gilenya(® ...... -remitting multiple sclerosis?
@ast
How does fingolimod (gilenya(® ...... -remitting multiple sclerosis?
@en
P2093
P2860
P50
P356
P1476
How does fingolimod (gilenya(® ...... -remitting multiple sclerosis?
@en
P2093
Alenka Horvat Ledinek
Egon Kurča
Eva Havrdová
Franz Fazekas
Gábor Jakab
Jörg Kraus
L'ubomír Lisý
Larysa Sokolova
Latchezar Traykov
P2860
P356
10.3389/FNEUR.2013.00010
P577
2013-05-01T00:00:00Z